Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Medpace Holdings Inc
01PCurrent price
294.5 EUR
+0.3 EUR (+0.10%)
Last closed
314.22 USD
Company
www.medpace.com
ISIN
US58506Q1094
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
Frankfurt Exchange
Capitalization
10 263 766 016 USD
Yield for 12 month
+16.54 %
1Y
3Y
5Y
10Y
15Y
01P
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio. Address: 5375 Medpace Way, Cincinnati, OH, United States, 45227
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
355.25 USDP/E ratio
28.8906Dividend Yield
–Current Year
+1 885 842 000 USD
Last Year
+1 459 996 000 USD
Current Quarter
+533 317 000 USD
Last Quarter
+528 104 000 USD
Current Year
+524 505 000 USD
Last Year
+432 438 000 USD
Current Quarter
-204 086 000 USD
Last Quarter
+146 603 000 USD
Key Figures 01P
1 year
3 years
5 years
10 years
EBITDA
437 528 992 USD
Operating Margin TTM
PE Ratio
28.8906
Return On Assets TTM
14.31 %
PEG Ratio
1.5708
Return On Equity TTM
54.08 %
Wall Street Target Price
355.25 USD
Revenue TTM
2 070 866 048 USD
Book Value
28.42 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
8.3 %
Dividend Yield
–
Gross Profit TTM
925 109 000 USD
Earnings per share
11.43 USD
Diluted Eps TTM
11.43 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
35.6 %
Profit Margin
17.66 %
Dividend Analytics 01P
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 01P
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 01P
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
28.8906
Forward PE
25.3807
Enterprise Value Revenue
4.701
Price Sales TTM
4.9563
Enterprise Value EBITDA
22.2503
Price Book MRQ
11.6443
Financials 01P
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 01P
For 52 weeks
239 USD
459.77 USD
50 Day MA
352.09 USD
Shares Short Prior Month
1 238 544
200 Day MA
375.52 USD
Short Ratio
2.9
Shares Short
1 110 631
Short Percent
5.36 %
BeatStart